Kristin M Burns1, Frank Evans, Gail D Pearson, Charles I Berul, Jonathan R Kaltman. 1. Heart Development and Structural Diseases Branch/Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. kristin.burns@nih.gov
Abstract
INTRODUCTION: Catheter ablation has been shown to be effective for pediatric tachyarrhythmias, but the associated charges and costs have not been described in the recent era. Understanding such contemporary trends may identify ways to keep an effective therapy affordable while optimizing clinical outcomes. METHODS: We used the 1997-2009 Kids' Inpatient Databases to examine trends in charges and costs for pediatric catheter ablation and identify determinants of temporal changes. RESULTS: There were 7,130 discharges for catheter ablation in the sample. Mean age at ablation was 12.1 ± 0.2 years. Patients with congenital heart disease (CHD) made up 10% of the sample. Complications occurred in 8% of discharges. Mean total charges rose 219% above inflation (from $23,798 ± 1,072 in 1997 to $75,831 ± 2,065 in 2009). From 2003 to 2009, costs rose 25% (from $20,459 ± 780 in 2003 to $25,628 ± 992 in 2009). Charges for ablation increased markedly relative to surgical procedures, but with a similar slope to other catheter-based interventions. Multivariable analysis revealed that year (P < 0.0001), payer (P = 0.0002), CHD (P < 0.0001), valvular heart disease (P = 0.0004), cardiomyopathy (P = 0.0009), hospital region (P < 0.0001), length of stay (P < 0.0001), and complications (P < 0.0001) predicted increased charges. The same factors also predicted increased costs. Charges and costs varied considerably by region, particularly for high-volume centers (P < 0.0001). CONCLUSIONS: Charges and costs for pediatric catheter ablation increased relative to other procedures and significantly outstripped inflation. Further study of complications, length of stay, and regional differences may help control rising costs while maintaining quality of care.
INTRODUCTION: Catheter ablation has been shown to be effective for pediatric tachyarrhythmias, but the associated charges and costs have not been described in the recent era. Understanding such contemporary trends may identify ways to keep an effective therapy affordable while optimizing clinical outcomes. METHODS: We used the 1997-2009 Kids' Inpatient Databases to examine trends in charges and costs for pediatric catheter ablation and identify determinants of temporal changes. RESULTS: There were 7,130 discharges for catheter ablation in the sample. Mean age at ablation was 12.1 ± 0.2 years. Patients with congenital heart disease (CHD) made up 10% of the sample. Complications occurred in 8% of discharges. Mean total charges rose 219% above inflation (from $23,798 ± 1,072 in 1997 to $75,831 ± 2,065 in 2009). From 2003 to 2009, costs rose 25% (from $20,459 ± 780 in 2003 to $25,628 ± 992 in 2009). Charges for ablation increased markedly relative to surgical procedures, but with a similar slope to other catheter-based interventions. Multivariable analysis revealed that year (P < 0.0001), payer (P = 0.0002), CHD (P < 0.0001), valvular heart disease (P = 0.0004), cardiomyopathy (P = 0.0009), hospital region (P < 0.0001), length of stay (P < 0.0001), and complications (P < 0.0001) predicted increased charges. The same factors also predicted increased costs. Charges and costs varied considerably by region, particularly for high-volume centers (P < 0.0001). CONCLUSIONS: Charges and costs for pediatric catheter ablation increased relative to other procedures and significantly outstripped inflation. Further study of complications, length of stay, and regional differences may help control rising costs while maintaining quality of care.
Authors: John K Triedman; Mark E Alexander; Barry A Love; Kathryn K Collins; Charles I Berul; Laura M Bevilacqua; Edward P Walsh Journal: J Am Coll Cardiol Date: 2002-06-05 Impact factor: 24.094
Authors: Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland Journal: Health Aff (Millwood) Date: 2010-01-28 Impact factor: 6.301
Authors: Sara K Pasquali; Jie-Lena Sun; Phil d'Almada; Robert D B Jaquiss; Andrew J Lodge; Neal Miller; Alex R Kemper; Carole M Lannon; Jennifer S Li Journal: Circ Cardiovasc Qual Outcomes Date: 2011-04-19
Authors: George F Van Hare; Harold Javitz; Dorit Carmelli; J Philip Saul; Ronn E Tanel; Peter S Fischbach; Ronald J Kanter; Michael Schaffer; Ann Dunnigan; Steven Colan; Gerald Serwer Journal: J Cardiovasc Electrophysiol Date: 2004-07
Authors: Anthony I Squillaro; Shadassa Ourshalimian; Cory M McLaughlin; Ashwini Lakshmanan; Philippe Friedlich; Cynthia Gong; Ashley Song; Lorraine I Kelley-Quon Journal: J Surg Res Date: 2020-07-08 Impact factor: 2.192